 | • レポートコード：TPM-DJ096 • 出版社/出版日：Transparency Market Research / 2019年3月28日 • レポート形態：英文、PDF、173ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、ヘモグロビンA1c検査装置の世界市場について調べ、ヘモグロビンA1c検査装置の市場規模、市場動向、市場シェア、市場環境、市場予測、関連企業情報などをまとめました。 |
Global Hemoglobin A1c Testing Devices Market: Overview
The global hemoglobin A1c testing devices market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on technology, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography, thereby presenting a thorough analysis of the overall competitive scenario in the global hemoglobin A1c testing devices market.
Global Hemoglobin A1c Testing Devices Market: Key Segments
In terms of technology, the global hemoglobin A1c testing devices market has been segmented into ion-exchange high-performance liquid chromatography (hplc), immunoassay, boronate affinity chromatography, direct enzymatic assay, and others. Based on end-user, the market has been classified into laboratories testing and point-of-care (POC) settings. The laboratories testing segment has been further segmented into commercial laboratory and others. The point-of-care (POC) settings segment has been further categorized into hospitals, home care, clinics, and others. The POC settings segment is anticipated to expand at a significant CAGR during the forecast period. The market has been analyzed based on price variations, technology trends, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Hemoglobin A1c Testing Devices Market: Regional Outlook
In terms of region, the global hemoglobin A1c testing devices market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key companies profiled in the global hemoglobin A1c testing devices market include Siemens Healthineers, Abbott Laboratories, Arkray, Inc., Bio-Rad Laboratories, Inc., Polymer Technology Systems, Inc., Danaher Corporation (Beckman Coulter), EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Tosoh Corporation, and Trinity Biotech plc.
The global hemoglobin A1c testing devices market has been segmented as follows:
Global Hemoglobin A1c Testing Devices Market, by Technology
Ion-exchange High-performance Liquid Chromatography (HPLC)
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Others
Global Hemoglobin A1c Testing Devices Market, by End-user
Laboratory Testing End-user
Commercial Laboratory
Others
Point-of-care (POC) Testing End-user
Hospitals
Home Care
Clinics
Others
Global Hemoglobin A1c Testing Devices Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Israel
Rest of Middle East & Africa
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Acronyms Used
3. Research Methodology
4. Executive Summary
5. Market Overview
5.1. Product Overview
5.2. Market Dynamics
5.2.1. Drivers
5.2.1.1. High Prevalence and Increase in the Incidence of Diabetes
5.2.1.2. Increase in the Geriatric Population
5.2.1.3. Employer Sponsored Medical Programs
5.2.1.4. Improving Health Care Facilities
5.2.1.5. Growing Medical Tourism
5.2.2. Restraints
5.2.2.1. Absence of Health Insurance Schemes in Developing Countries
5.2.2.2. Lack of Medical Professionals in Developing Countries
5.2.3. Opportunities
5.2.3.1. Unmet Clinical Needs in Developing Countries
5.2.3.2. Technologically Advanced and Innovative Solutions
5.3. Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, 2016?2026
5.4. Global Hemoglobin A1c Testing Devices Market Outlook
5.5. Key Industry Developments
5.6. Market Regulations
5.6.1. U.S. Regulations for Medical Devices
5.6.2. Europe: Regulations for Medical Devices
5.6.3. Asia Pacific: Regulations
5.7. Recent Approved Brands for HbA1c Test, 2018
5.8. Quantitative Analysis, by Test Type
6. Global Hemoglobin A1c Testing Devices Market Analysis, by Technology
6.1. Introduction
6.2. Key Findings
6.3. Global Hemoglobin A1c Testing Devices Market Value Share Analysis, by Technology
6.4. Global Hemoglobin A1c Testing Devices Market Value Forecast, by Technology, 2016?2026
6.4.1. Ion-exchange High-performance Liquid Chromatography (HPLC)
6.4.2. Immunoassay
6.4.3. Boronate Affinity Chromatography
6.4.4. Direct Enzymatic Assay
6.4.5. Others
6.5. Global Hemoglobin A1c Testing Devices Market Attractiveness, by Technology
7. Global Hemoglobin A1c Testing Devices Market Analysis, by End-user
7.1. Introduction
7.2. Key Findings
7.3. Market Value Share Analysis, by End-user
7.4. Market Value Forecast, by End-user, 2016-2026
7.4.1. Laboratory Testing End-user
7.4.1.1. Commercial Laboratory
7.4.1.2. Others
7.4.2. Point-of-care (POC) Setting
7.4.2.1. Hospitals
7.4.2.2. Home Care
7.4.2.3. Clinics
7.4.2.4. Others
7.5. Market Attractiveness, by End-user
8. Global Hemoglobin A1c Testing Devices Market Analysis and Forecasts, by Region
8.1. Introduction
8.2. Regional Outlook
8.3. Global Hemoglobin A1c Testing Devices Market Value Forecast, by Region, 2016–2026
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Rest of the World
8.4. Global Hemoglobin A1c Testing Devices Market Attractiveness Analysis, by Region
9. North America Hemoglobin A1c Testing Devices Market Analysis
9.1. Key Findings
9.2. North America Market Value Forecast, by Country, 2016?2026
9.2.1. U.S.
9.2.2. Canada
9.3. North America Market Value Forecast, by Technology, 2016?2026
9.3.1. Ion-exchange High-performance Liquid Chromatography (HPLC)
9.3.2. Immunoassay
9.3.3. Boronate Affinity Chromatography
9.3.4. Direct Enzymatic Assay
9.3.5. Others
9.4. North America Market Value Forecast, by End-user, 2016-2026
9.4.1. Laboratory Testing End-user
9.4.1.1. Commercial Laboratory
9.4.1.2. Others
9.4.2. Point-of-care (POC) Setting
9.4.2.1. Hospitals
9.4.2.2. Home Care
9.4.2.3. Clinics
9.4.2.4. Others
9.5. North America Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Technology
9.5.3. By End-user
10. Europe Hemoglobin A1c Testing Devices Market Analysis
10.1. Key Findings
10.2. Europe Market Value Forecast, by Country, 2016?2026
10.2.1. Germany
10.2.2. U.K.
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Europe Market Value Forecast, by Technology, 2016?2026
10.3.1. Ion-exchange High-performance Liquid Chromatography (HPLC)
10.3.2. Immunoassay
10.3.3. Boronate Affinity Chromatography
10.3.4. Direct Enzymatic Assay
10.3.5. Others
10.4. Europe Market Value Forecast, by End-user, 2016-2026
10.4.1. Laboratory Testing End-user
10.4.1.1. Commercial Laboratory
10.4.1.2. Others
10.4.2. Point-of-care (POC) Setting
10.4.2.1. Hospitals
10.4.2.2. Home Care
10.4.2.3. Clinics
10.4.2.4. Others
10.5. Europe Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Technology
10.5.3. By End-user
11. Asia Pacific Hemoglobin A1c Testing Devices Market Analysis
11.1. Key Findings
11.2. Asia Pacific Market Value Forecast, by Country, 2016?2026
11.2.1. China
11.2.2. India
11.2.3. Japan
11.2.4. Australia & New Zealand
11.2.5. Rest of Asia Pacific
11.3. Asia Pacific Market Value Forecast, by Technology, 2016?2026
11.3.1. Ion-exchange High-performance Liquid Chromatography (HPLC)
11.3.2. Immunoassay
11.3.3. Boronate Affinity Chromatography
11.3.4. Direct Enzymatic Assay
11.3.5. Others
11.4. Asia Pacific Market Value Forecast, by End-user, 2016-2026
11.4.1. Laboratory Testing End-user
11.4.1.1. Commercial Laboratory
11.4.1.2. Others
11.4.2. Point-of-care (POC) Setting
11.4.2.1. Hospitals
11.4.2.2. Home Care
11.4.2.3. Clinics
11.4.2.4. Others
11.5. Asia Pacific Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Technology
11.5.3. By End-user
12. Rest of the World Hemoglobin A1c Testing Devices Market Analysis
12.1. Key Findings
12.2. Rest of the World Market Value Forecast, by Country, 2016?2026
12.2.1. Brazil
12.2.2. GCC Countries
12.2.3. Rest of the World
12.3. Rest of the World Market Value Forecast, by Technology, 2016?2026
12.3.1. Ion-exchange High-performance Liquid Chromatography (HPLC)
12.3.2. Immunoassay
12.3.3. Boronate Affinity Chromatography
12.3.4. Direct Enzymatic Assay
12.3.5. Others
12.4. Rest of the World Market Value Forecast, by End-user, 2016-2026
12.4.1. Laboratory Testing End-user
12.4.1.1. Commercial Laboratory
12.4.1.2. Others
12.4.2. Point-of-care (POC) Setting
12.4.2.1. Hospitals
12.4.2.2. Home Care
12.4.2.3. Clinics
12.4.2.4. Others
12.5. Asia Pacific Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Technology
12.5.3. By End-user
13. Competitive Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies) Company Profiles
13.2. Market Share Analysis, by Top Company Ranking, 2017
13.3. Competitive Business Strategies
13.4. Company Profiles
13.4.1. Abbott Laboratories
13.4.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.1.2. Financial Overview
13.4.1.3. Product Portfolio
13.4.1.4. SWOT Analysis
13.4.1.5. Strategic Overview
13.4.2. Arkray, Inc.
13.4.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.2.2. Financial Overview
13.4.2.3. Product Portfolio
13.4.2.4. SWOT Analysis
13.4.2.5. Strategic Overview
13.4.3. Bio-Rad Laboratories, inc.
13.4.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.3.2. Financial Overview
13.4.3.3. Product Portfolio
13.4.3.4. SWOT Analysis
13.4.3.5. Strategic Overview
13.4.4. Polymer Technology Systems, Inc.
13.4.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.4.2. Financial Overview
13.4.4.3. Product Portfolio
13.4.4.4. SWOT Analysis
13.4.4.5. Strategic Overview
13.4.5. Danaher Corporation (Beckman Coulter)
13.4.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.5.2. Financial Overview
13.4.5.3. Product Portfolio
13.4.5.4. SWOT Analysis
13.4.5.5. Strategic Overview
13.4.6. EKF Diagnostics Holdings plc
13.4.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.6.2. Financial Overview
13.4.6.3. Product Portfolio
13.4.6.4. SWOT Analysis
13.4.6.5. Strategic Overview
13.4.7. F. Hoffmann-La Roche Ltd.
13.4.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.7.2. Financial Overview
13.4.7.3. Product Portfolio
13.4.7.4. SWOT Analysis
13.4.7.5. Strategic Overview
13.4.8. Menarini Group
13.4.8.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.8.2. Financial Overview
13.4.8.3. Product Portfolio
13.4.8.4. SWOT Analysis
13.4.8.5. Strategic Overview
13.4.9. Sebia
13.4.9.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.9.2. Financial Overview
13.4.9.3. Product Portfolio
13.4.9.4. SWOT Analysis
13.4.9.5. Strategic Overview
13.4.10. Tosoh Corporation
13.4.10.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.10.2. Financial Overview
13.4.10.3. Product Portfolio
13.4.10.4. SWOT Analysis
13.4.10.5. Strategic Overview
13.4.11. Trinity Biotech plc.
13.4.11.1. Company Overview (Headquarters, Business Segments, Employee Strength)
13.4.11.2. Financial Overview
13.4.11.3. Product Portfolio
13.4.11.4. SWOT Analysis
13.4.11.5. Strategic Overview
Table 01: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 02: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 03: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016–2026
Table 04: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016–2026
Table 05: Global Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 08: U.S. Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 09: Canada Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 10: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016–2026
Table 12: North America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016–2026
Table 13: U.S. Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 14: U.S. Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016–2026
Table 15: U.S. Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016–2026
Table 16: Canada Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 17: Canada Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016–2026
Table 18: Canada Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016–2026
Table 19: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 21: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 22: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratory Testing End-user, 2016–2026
Table 23: Europe Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Testing End-user, 2016–2026
Table 24: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 26: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 27: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016–2026
Table 28: Asia Pacific Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016–2026
Table 29: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 30: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 31: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 32: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016–2026
Table 33: Latin America Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016–2026
Table 34: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 35: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 36: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 37: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Laboratories, 2016–2026
Table 38: Middle East & Africa Hemoglobin A1c Testing Devices Market Value (US$ Mn) Forecast, by Point-of-Care (POC) Settings, 2016–2026